Download - Neonatal Jaundice
-
5/25/2018 Neonatal Jaundice
1/24
Neonatal jaundiceor Neonatal hyperbilirubinemia, or Neonatal icterus(from the Greek
word ), attributive adjective: icteric, is a yellowing of theskinand other tissues of a
newborninfant.Abilirubinlevel of more than 85 mol/l (5mg/dL) manifests
clinicaljaundiceinneonateswhereas in adults a level of 34 mol/l (2mg/dL) would lookicteric.In
newborns, jaundice is detected by blanching the skin with digital pressureso that it revealsunderlying skin and subcutaneous tissue.
[1]Jaundiced newborns have an apparent ictericsclera,
and yellowing of the face, extending down onto the chest.
In neonates, the dermalicterusis first noted in the face and as the bilirubin level rises proceeds
caudal to the trunk and then to the extremities.[2]
This condition is common in newborns affecting
over half (5060%) of all babies in the first week of life.[3]
Notoriously inaccuraterules of thumbhave been applied to thephysical examof the jaundiced
infant.[citation needed]
Some include estimation of serumbilirubinbased on appearance. One such rule of
thumbincludes infants whose jaundice is restricted to the face and part of the trunk above
theumbilicus,have thebilirubinless than 204 mol/l (12mg/dL) (less dangerous level). Infants
whose palms and soles are yellow, have serum bilirubin level over 255 mol/l (15mg/dL) (more
serious level). Studies have shown that trained examiners assessment of levels of jaundice show
moderate agreement with icterometer bilirubin measurements.[2]
In infants, jaundice can be
measured usinginvasiveor non-invasive methods.
http://en.wikipedia.org/wiki/Skinhttp://en.wikipedia.org/wiki/Skinhttp://en.wikipedia.org/wiki/Skinhttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Jaundicehttp://en.wikipedia.org/wiki/Jaundicehttp://en.wikipedia.org/wiki/Jaundicehttp://en.wikipedia.org/wiki/Neonateshttp://en.wikipedia.org/wiki/Neonateshttp://en.wikipedia.org/wiki/Neonateshttp://en.wikipedia.org/wiki/Icterichttp://en.wikipedia.org/wiki/Icterichttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-family-1http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-family-1http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-family-1http://en.wikipedia.org/wiki/Sclerahttp://en.wikipedia.org/wiki/Sclerahttp://en.wikipedia.org/wiki/Sclerahttp://en.wikipedia.org/wiki/Icterus_(medicine)http://en.wikipedia.org/wiki/Icterus_(medicine)http://en.wikipedia.org/wiki/Icterus_(medicine)http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-3http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-3http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-3http://en.wikipedia.org/wiki/Rules_of_thumbhttp://en.wikipedia.org/wiki/Rules_of_thumbhttp://en.wikipedia.org/wiki/Rules_of_thumbhttp://en.wikipedia.org/wiki/Physical_examhttp://en.wikipedia.org/wiki/Physical_examhttp://en.wikipedia.org/wiki/Physical_examhttp://en.wikipedia.org/wiki/Wikipedia:Citation_neededhttp://en.wikipedia.org/wiki/Wikipedia:Citation_neededhttp://en.wikipedia.org/wiki/Wikipedia:Citation_neededhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Navelhttp://en.wikipedia.org/wiki/Navelhttp://en.wikipedia.org/wiki/Navelhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Invasiveness_of_surgical_procedureshttp://en.wikipedia.org/wiki/Invasiveness_of_surgical_procedureshttp://en.wikipedia.org/wiki/Invasiveness_of_surgical_procedureshttp://en.wikipedia.org/wiki/Invasiveness_of_surgical_procedureshttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Navelhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Wikipedia:Citation_neededhttp://en.wikipedia.org/wiki/Physical_examhttp://en.wikipedia.org/wiki/Rules_of_thumbhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-3http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-ReferenceA-2http://en.wikipedia.org/wiki/Icterus_(medicine)http://en.wikipedia.org/wiki/Sclerahttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-family-1http://en.wikipedia.org/wiki/Icterichttp://en.wikipedia.org/wiki/Neonateshttp://en.wikipedia.org/wiki/Jaundicehttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Skin -
5/25/2018 Neonatal Jaundice
2/24
Classification[edit]Physiological jaundice[edit]
Mostinfantsdevelop visible jaundice due to elevation of unconjugated bilirubin concentration during
their first week. This common condition is called physiological jaundice. This patternofhyperbilirubinemiahas been classified into two functionally distinct periods.
Phase one
1. Term infants - jaundice lasts for about 10 days with a rapid rise of serum bilirubin up to
204 mol/l (12mg/dL).
2. Preterm infants - jaundice lasts for about two weeks, with a rapid rise of serum bilirubin up to
255 mol/l (15mg/dL).
Phase two - bilirubin levels decline to about 34 mol/l (2mg/dL) for two weeks, eventually
mimicking adult values.
1. Preterm infants - phase two can last more than one month.
2. Exclusively breastfed infants - phase two can last more than one month.
Causes[edit]
Mechanism involved in physiological jaundice are mainly:
Relatively low activity of the enzymeglucuronosyltransferase which normally
convertsunconjugated bilirubinto conjugated bilirubin that can be excreted into the
gastrointestinal tract.[4]Before birth, this enzyme is actively down-regulated, since bilirubin needs
to remain unconjugated in order to cross the placenta to avoid being accumulated in the
fetus.[5]
After birth, it takes some time for this enzyme to gain function.
Shorter life span of fetal red blood cells,[4]
being approximately 80 to 90 days in a full
terminfant,[6]
compared to 100 to 120 days in adults.
Relatively low conversion of bilirubin tourobilinogenby theintestinal flora,resulting in relatively
high absorption of bilirubin back into the circulation.[4]
http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=1http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=1http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=1http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=2http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=2http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=2http://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=3http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=3http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=3http://en.wikipedia.org/wiki/Glucuronosyltransferasehttp://en.wikipedia.org/wiki/Glucuronosyltransferasehttp://en.wikipedia.org/wiki/Glucuronosyltransferasehttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-5http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-5http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-5http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-6http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-6http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-6http://en.wikipedia.org/wiki/Urobilinogenhttp://en.wikipedia.org/wiki/Urobilinogenhttp://en.wikipedia.org/wiki/Urobilinogenhttp://en.wikipedia.org/wiki/Intestinal_florahttp://en.wikipedia.org/wiki/Intestinal_florahttp://en.wikipedia.org/wiki/Intestinal_florahttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Intestinal_florahttp://en.wikipedia.org/wiki/Urobilinogenhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-6http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-5http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-jain2002-4http://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Glucuronosyltransferasehttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=3http://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Infanthttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=2http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=1 -
5/25/2018 Neonatal Jaundice
3/24
Pathological Jaundice of Neonates (Unconjugated PathologicalHyperbilirubinemia)[edit]
Any of the following features characterizes pathological jaundice:
1. Clinical jaundice appearing in the first 24 hours or greater than 14 days of life.
2. Increases in the level of total bilirubin by more than 8.5 mol/l (0.5mg/dL) per hour or
(85 mol/l) 5mg/dL per 24 hours.
3. Total bilirubin more than 331.5 mol/l (19.5mg/dL) (hyperbilirubinemia).
4. Direct bilirubin more than 34 mol/l (2.0mg/dL).
http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=4http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=4http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=4http://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=4 -
5/25/2018 Neonatal Jaundice
4/24
Causes of jaundice[edit]
In neonates, jaundice tends to develop because of two factors - the breakdown offetal
hemoglobinas it is replaced withadult hemoglobinand the relatively immature hepatic metabolic
pathways which are unable to conjugate and so excrete bilirubin as quickly as an adult. This causes
an accumulation of bilirubin in the blood (hyperbilirubinemia), leading to the symptoms of jaundice.
If the neonatal jaundicedoes not clear up with simplephototherapy,other causes such asbiliary
atresia,PFIC, bile duct paucity,Alagille syndrome,alpha 1-antitrypsin deficiency, and other pediatric
liver diseases should be considered. The evaluation for these will include blood work and a variety of
diagnostic tests. Prolonged neonatal jaundice is serious and should be followed up promptly.
Severe neonatal jaundice may indicate the presence of other conditions contributing to the elevated
bilirubin levels, of which there are a large variety of possibilities (see below). These should be
detected or excluded as part of thedifferential diagnosisto prevent the development of
complications. They can be grouped into the following categories:
Neonatal jaundice
Unconjugatedbilirubin
Conjugated
bilirubin
Pathologic Physiologicaljaundice of
Neonates
Hepatic Post-
hepatic
Hemolytic Non-hemolytic
Intrinsiccauses
Extrinsiccauses
Non Conjugated[edit]
Hemolytic[edit]
http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=6http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=6http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=6http://en.wikipedia.org/wiki/Fetal_hemoglobinhttp://en.wikipedia.org/wiki/Fetal_hemoglobinhttp://en.wikipedia.org/wiki/Fetal_hemoglobinhttp://en.wikipedia.org/wiki/Fetal_hemoglobinhttp://en.wikipedia.org/wiki/Hemoglobinhttp://en.wikipedia.org/wiki/Hemoglobinhttp://en.wikipedia.org/wiki/Hemoglobinhttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/wiki/Differential_diagnosishttp://en.wikipedia.org/wiki/Differential_diagnosishttp://en.wikipedia.org/wiki/Differential_diagnosishttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Conjugated_bilirubinhttp://en.wikipedia.org/wiki/Conjugated_bilirubinhttp://en.wikipedia.org/wiki/Pathologyhttp://en.wikipedia.org/wiki/Physiological_jaundice_of_Neonateshttp://en.wikipedia.org/wiki/Physiological_jaundice_of_Neonateshttp://en.wikipedia.org/wiki/Physiological_jaundice_of_Neonateshttp://en.wikipedia.org/wiki/Hepatichttp://en.wikipedia.org/wiki/Hemolysishttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=7http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=7http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=7http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=8http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=8http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=8http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=8http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=7http://en.wikipedia.org/wiki/Hemolysishttp://en.wikipedia.org/wiki/Hepatichttp://en.wikipedia.org/wiki/Physiological_jaundice_of_Neonateshttp://en.wikipedia.org/wiki/Physiological_jaundice_of_Neonateshttp://en.wikipedia.org/wiki/Physiological_jaundice_of_Neonateshttp://en.wikipedia.org/wiki/Pathologyhttp://en.wikipedia.org/wiki/Conjugated_bilirubinhttp://en.wikipedia.org/wiki/Conjugated_bilirubinhttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Unconjugated_bilirubinhttp://en.wikipedia.org/wiki/Differential_diagnosishttp://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Hyperbilirubinemiahttp://en.wikipedia.org/wiki/Hemoglobinhttp://en.wikipedia.org/wiki/Fetal_hemoglobinhttp://en.wikipedia.org/wiki/Fetal_hemoglobinhttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=6 -
5/25/2018 Neonatal Jaundice
5/24
Intrinsic causes of hemolysis[edit]
Membrane conditions
Spherocytosis
Hereditary elliptocytosis
Systemic conditions
Sepsis
Arteriovenous malformation
Enzyme conditions
Glucose-6-phosphate dehydrogenase deficiency(also called G6PD deficiency)
Pyruvate kinase deficiency
Globin synthesis defect
sickle cell disease
Alpha-thalassemia,e.g. HbH disease
Extrinsic causes of hemolysis[edit]
Alloimmunity(The neonatal orcord bloodgives a positivedirect Coombs testand the maternal
blood gives a positiveindirect Coombs test)
Hemolytic disease of the newborn (ABO)[1]
Rh disease[1]
Hemolytic disease of the newborn (anti-Kell)
Hemolytic disease of the newborn (anti-Rhc)
Other blood type mismatches causinghemolytic disease of the newborn
Non-hemolytic causes[edit]
Breast milk jaundice
Cephalohematoma
Polycythemia
Urinary tract infection Sepsis
Hypothyroidism
Gilbert's syndrome
Crigler-Najjar syndrome
High GI obstruction
http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=9http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=9http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=9http://en.wikipedia.org/wiki/Spherocytosishttp://en.wikipedia.org/wiki/Spherocytosishttp://en.wikipedia.org/wiki/Hereditary_elliptocytosishttp://en.wikipedia.org/wiki/Hereditary_elliptocytosishttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Arteriovenous_malformationhttp://en.wikipedia.org/wiki/Arteriovenous_malformationhttp://en.wikipedia.org/wiki/Glucose-6-phosphate_dehydrogenase_deficiencyhttp://en.wikipedia.org/wiki/Glucose-6-phosphate_dehydrogenase_deficiencyhttp://en.wikipedia.org/wiki/Pyruvate_kinase_deficiencyhttp://en.wikipedia.org/wiki/Pyruvate_kinase_deficiencyhttp://en.wikipedia.org/wiki/Sickle_cell_diseasehttp://en.wikipedia.org/wiki/Sickle_cell_diseasehttp://en.wikipedia.org/wiki/Alpha-thalassemiahttp://en.wikipedia.org/wiki/Alpha-thalassemiahttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=10http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=10http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=10http://en.wikipedia.org/wiki/Alloimmunityhttp://en.wikipedia.org/wiki/Alloimmunityhttp://en.wikipedia.org/wiki/Cord_bloodhttp://en.wikipedia.org/wiki/Cord_bloodhttp://en.wikipedia.org/wiki/Cord_bloodhttp://en.wikipedia.org/wiki/Coombs_test#Direct_Coombs_testhttp://en.wikipedia.org/wiki/Coombs_test#Direct_Coombs_testhttp://en.wikipedia.org/wiki/Coombs_test#Direct_Coombs_testhttp://en.wikipedia.org/wiki/Coombs_test#Indirect_Coombs_esthttp://en.wikipedia.org/wiki/Coombs_test#Indirect_Coombs_esthttp://en.wikipedia.org/wiki/Coombs_test#Indirect_Coombs_esthttp://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(ABO)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(ABO)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(ABO)http://en.wikipedia.org/wiki/Rh_diseasehttp://en.wikipedia.org/wiki/Rh_diseasehttp://en.wikipedia.org/wiki/Rh_diseasehttp://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(anti-Kell)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(anti-Kell)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(anti-Rhc)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(anti-Rhc)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newbornhttp://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newbornhttp://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newbornhttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=11http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=11http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=11http://en.wikipedia.org/wiki/Cephalohematomahttp://en.wikipedia.org/wiki/Cephalohematomahttp://en.wikipedia.org/wiki/Polycythemiahttp://en.wikipedia.org/wiki/Polycythemiahttp://en.wikipedia.org/wiki/Urinary_tract_infectionhttp://en.wikipedia.org/wiki/Urinary_tract_infectionhttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Hypothyroidismhttp://en.wikipedia.org/wiki/Hypothyroidismhttp://en.wikipedia.org/wiki/Gilbert%27s_syndromehttp://en.wikipedia.org/wiki/Gilbert%27s_syndromehttp://en.wikipedia.org/wiki/Crigler-Najjar_syndromehttp://en.wikipedia.org/wiki/Crigler-Najjar_syndromehttp://en.wikipedia.org/wiki/Crigler-Najjar_syndromehttp://en.wikipedia.org/wiki/Gilbert%27s_syndromehttp://en.wikipedia.org/wiki/Hypothyroidismhttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Urinary_tract_infectionhttp://en.wikipedia.org/wiki/Polycythemiahttp://en.wikipedia.org/wiki/Cephalohematomahttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=11http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newbornhttp://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(anti-Rhc)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(anti-Kell)http://en.wikipedia.org/wiki/Rh_diseasehttp://en.wikipedia.org/wiki/Rh_diseasehttp://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(ABO)http://en.wikipedia.org/wiki/Hemolytic_disease_of_the_newborn_(ABO)http://en.wikipedia.org/wiki/Coombs_test#Indirect_Coombs_esthttp://en.wikipedia.org/wiki/Coombs_test#Direct_Coombs_testhttp://en.wikipedia.org/wiki/Cord_bloodhttp://en.wikipedia.org/wiki/Alloimmunityhttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=10http://en.wikipedia.org/wiki/Alpha-thalassemiahttp://en.wikipedia.org/wiki/Sickle_cell_diseasehttp://en.wikipedia.org/wiki/Pyruvate_kinase_deficiencyhttp://en.wikipedia.org/wiki/Glucose-6-phosphate_dehydrogenase_deficiencyhttp://en.wikipedia.org/wiki/Arteriovenous_malformationhttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Hereditary_elliptocytosishttp://en.wikipedia.org/wiki/Spherocytosishttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=9 -
5/25/2018 Neonatal Jaundice
6/24
Conjugated[edit]
Hepatic causes[edit]
Infections
Sepsis
Hepatitis A
Hepatitis B
TORCH infections
Metabolic
Galactosemia
Alpha-1-antitrypsin deficiency,which is commonly missed, and must be considered in DDx
Cystic fibrosis
Dubin-Johnson Syndrome
Rotor syndrome
Drugs
Total parenteral nutrition
Idiopathic
Post-hepatic[edit]
Biliary atresiaorbile ductobstruction
Alagille syndrome
Choledochal cyst
Non-organic causes[edit]
Breastfeeding failure jaundice[edit]
"Breastfeeding jaundice" or "lack of breastfeeding jaundice," is caused by insufficient breast milk
intake,[7]
resulting in inadequate quantities of bowel movementsto remove bilirubin from the body.
This can usually be ameliorated by frequent breastfeeding sessions of sufficient duration to stimulate
adequate milk production.
Breast Milk jaundice[edit]
Whereas breast feedingjaundice is a mechanical problem, breast milkjaundice is a biochemical
occurrence and the higher bilirubin possibly acts as an antioxidant. Breast milk jaundice occurs later
in the newborn period, with the bilirubin level usually peaking in the sixth to 14th days of life. This
late-onset jaundice may develop in up to one third of healthy breastfed infants.[8]
http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=12http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=12http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=12http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=13http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=13http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=13http://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/wiki/Hepatitis_Bhttp://en.wikipedia.org/wiki/Hepatitis_Bhttp://en.wikipedia.org/wiki/TORCH_syndromehttp://en.wikipedia.org/wiki/TORCH_syndromehttp://en.wikipedia.org/wiki/Galactosemiahttp://en.wikipedia.org/wiki/Galactosemiahttp://en.wikipedia.org/wiki/Alpha-1-antitrypsin_deficiencyhttp://en.wikipedia.org/wiki/Alpha-1-antitrypsin_deficiencyhttp://en.wikipedia.org/wiki/Cystic_fibrosishttp://en.wikipedia.org/wiki/Cystic_fibrosishttp://en.wikipedia.org/wiki/Dubin-Johnson_Syndromehttp://en.wikipedia.org/wiki/Dubin-Johnson_Syndromehttp://en.wikipedia.org/wiki/Rotor_syndromehttp://en.wikipedia.org/wiki/Rotor_syndromehttp://en.wikipedia.org/wiki/Total_parenteral_nutritionhttp://en.wikipedia.org/wiki/Total_parenteral_nutritionhttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=14http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=14http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=14http://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/wiki/Bile_ducthttp://en.wikipedia.org/wiki/Bile_ducthttp://en.wikipedia.org/wiki/Bile_ducthttp://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=15http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=15http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=15http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=16http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=16http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=16http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-GarfunkelKaczorowski2002-7http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-GarfunkelKaczorowski2002-7http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-GarfunkelKaczorowski2002-7http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=17http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=17http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=17http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-8http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-8http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-8http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-8http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=17http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-GarfunkelKaczorowski2002-7http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=16http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=15http://en.wikipedia.org/wiki/Alagille_syndromehttp://en.wikipedia.org/wiki/Bile_ducthttp://en.wikipedia.org/wiki/Biliary_atresiahttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=14http://en.wikipedia.org/wiki/Total_parenteral_nutritionhttp://en.wikipedia.org/wiki/Rotor_syndromehttp://en.wikipedia.org/wiki/Dubin-Johnson_Syndromehttp://en.wikipedia.org/wiki/Cystic_fibrosishttp://en.wikipedia.org/wiki/Alpha-1-antitrypsin_deficiencyhttp://en.wikipedia.org/wiki/Galactosemiahttp://en.wikipedia.org/wiki/TORCH_syndromehttp://en.wikipedia.org/wiki/Hepatitis_Bhttp://en.wikipedia.org/wiki/Sepsishttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=13http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=12 -
5/25/2018 Neonatal Jaundice
7/24
First, at birth, the gut is sterile, and normal gut flora takes time to establish. The bacteria in the
adult gut convert conjugatedbilirubintostercobilinogenwhich is then oxidized tostercobilinand
excreted in the stool. In the absence of sufficient bacteria, the bilirubin is de-conjugated by brush
border -glucuronidase and reabsorbed. This process of re-absorption is calledenterohepatic
circulation.It has been suggested that bilirubin uptake in the gut (enterohepatic circulation) isincreased in breast fed babies, possibly as the result of increased levels of epidermal growth
factor (EGF) in breast milk.[9]Breast milk also contains glucoronidase which will increase
deconjugation and enterohepatic recirculation of bilirubin.
Second, the breast-milk of some women contains a metabolite of progesterone called3-alpha-
20-beta pregnanediol.This substance inhibits the action of the enzyme uridine
diphosphoglucuronic acid (UDPGA)glucuronyl transferaseresponsible for conjugation and
subsequent excretion of bilirubin. In the newborn liver, activity of glucuronyl transferase is only at
0.1-1% of adult levels, so conjugation of bilirubin is already reduced. Further inhibition of bilirubin
conjugation leads to increased levels of bilirubin in the blood.[10]
However, these results have not
been supported by subsequent studies.[11]
Third, an enzyme in breast milk calledlipoprotein lipaseproduces increased concentration of
nonesterified free fatty acids that inhibit hepatic glucuronyl transferase, which again leads to
decreased conjugation and subsequent excretion of bilirubin.[12]
Despite the advantages of breast feeding, there is a strong association of breast feeding with
neonatal hyperbilirubinemia and thus risk ofkernicterus,though this is uncommon. Serum bilirubin
levels may reach as high as 30 mg/dL. Jaundice should be managed either with phototherapy or
with exchange blood transfusion as is needed. Breast feeds however need not be discontinued. The
child should be kept well hydrated and extra feeds given.
http://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Bilirubinhttp://en.wikipedia.org/wiki/Stercobilinogenhttp://en.wikipedia.org/wiki/Stercobilinogenhttp://en.wikipedia.org/wiki/Stercobilinogenhttp://en.wikipedia.org/wiki/Stercobilinhttp://en.wikipedia.org/wiki/Stercobilinhttp://en.wikipedia.org/wiki/Stercobilinhttp://en.wikipedia.org/wiki/Enterohepatic_circulationhttp://en.wikipedia.org/wiki/Enterohepatic_circulationhttp://en.wikipedia.org/wiki/Enterohepatic_circulationhttp://en.wikipedia.org/wiki/Enterohepatic_circulationhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-9http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-9http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-9http://en.wikipedia.org/wiki/Pregnanediolhttp://en.wikipedia.org/wiki/Pregnanediolhttp://en.wikipedia.org/wiki/Pregnanediolhttp://en.wikipedia.org/wiki/Pregnanediolhttp://en.wikipedia.org/wiki/Glucuronyl_transferasehttp://en.wikipedia.org/wiki/Glucuronyl_transferasehttp://en.wikipedia.org/wiki/Glucuronyl_transferasehttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-10http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-10http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-10http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-11http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-11http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-11http://en.wikipedia.org/wiki/Lipoprotein_lipasehttp://en.wikipedia.org/wiki/Lipoprotein_lipasehttp://en.wikipedia.org/wiki/Lipoprotein_lipasehttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-12http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-12http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-12http://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-12http://en.wikipedia.org/wiki/Lipoprotein_lipasehttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-11http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-10http://en.wikipedia.org/wiki/Glucuronyl_transferasehttp://en.wikipedia.org/wiki/Pregnanediolhttp://en.wikipedia.org/wiki/Pregnanediolhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-9http://en.wikipedia.org/wiki/Enterohepatic_circulationhttp://en.wikipedia.org/wiki/Enterohepatic_circulationhttp://en.wikipedia.org/wiki/Stercobilinhttp://en.wikipedia.org/wiki/Stercobilinogenhttp://en.wikipedia.org/wiki/Bilirubin -
5/25/2018 Neonatal Jaundice
8/24
Treatment[edit]
The bilirubin levels for initiative of phototherapy varies depends on the age and health status of the
newborn. However, any newborn with a total serum bilirubin greater than 359 mol/l ( 21mg/dL)
should receive phototherapy.[13]
Phototherapy[edit]
The use of phototherapy was first discovered, accidentally, at Rochford Hospital in Essex, England.
The ward sister (Charge Nurse) of the premature baby unit firmly believed that the infants under her
care benefited from fresh air and sunlight in the courtyard. Although this led to the first noticing of
jaundice being improved with sunlight, further studies only progressed when a vial of blood sent for
bilirubin measurement sat on a windowsill in the lab for several hours. The results indicated a much
lower level of bilirubin than expected based on the patient's visible jaundice. Further investigation
lead to the determination that blue light, wavelength of 420-448 nm, oxidized the bilirubin to
biliverdin, a soluble product that does not contribute tokernicterus.Although some pediatricians
began using phototherapy in the United Kingdom following Dr. Cremer's publishing the above facts
in the Lancetin 1958, most hospitals only began to regularly use phototherapy ten years later when
an American group independently made the same discovery.[14][15]
newborn infant undergoing (white light) phototherapy to treat neonatal jaundice
Infants with neonatal jaundice are treated with colored light called
phototherapy.Physiciansrandomly assigned 66 infants 35 weeks of gestation to receive
phototherapy. After 155 the levels of bilirubin, a yellowish bile pigment that in excessive amounts
causes jaundice, were decreased down to 0.270.25 mg/dl/h in the blue light. This suggests that
blue light therapy helps reduce high bilirubin levels that cause neonatal jaundice.[16]
Exposing infants to high levels of colored light changes trans-bilirubin to the more water soluble cis-
form which is excreted in the bile. Scientists studied 616 capillary blood samples from jaundiced
newborn infants. These samples were randomly divided into three groups. One group contained 133
samples and would receive phototherapy with blue light. Another group contained 202 samples
http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=19http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=19http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=19http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-AAP2004-13http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-AAP2004-13http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-AAP2004-13http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=20http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=20http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=20http://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-14http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-14http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-14http://en.wikipedia.org/wiki/Physicianshttp://en.wikipedia.org/wiki/Physicianshttp://en.wikipedia.org/wiki/Physicianshttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-16http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-16http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-16http://en.wikipedia.org/wiki/File:Jaundice_phototherapy.jpghttp://en.wikipedia.org/wiki/File:Jaundice_phototherapy.jpghttp://en.wikipedia.org/wiki/File:Jaundice_phototherapy.jpghttp://en.wikipedia.org/wiki/File:Jaundice_phototherapy.jpghttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-16http://en.wikipedia.org/wiki/Physicianshttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-14http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-14http://en.wikipedia.org/wiki/Kernicterushttp://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=20http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-AAP2004-13http://en.wikipedia.org/w/index.php?title=Neonatal_jaundice&action=edit§ion=19 -
5/25/2018 Neonatal Jaundice
9/24
would receive room light, or white light. The final group contained 215 samples, and were left in a
dark room. The total bilirubin levels were checked at 0, 2, 4, 6, 24, and 48 hours. There was a
significant decrease in bilirubin in the first group exposed to phototherapy after two hours, but no
change occurred in the white light and dark room group. After 6 hours, there was a significant
change in bilirubin level in the white light group but not the dark room group. It took 48 hours torecord a change in the dark room groups bilirubin level. Phototherapy is the most effective way of
breaking down a neonates bilirubin.[17]
Phototherapyworks through a process of isomerization that changes trans-bilirubin into the water-
soluble cis-bilirubin isomer.[18][19]
In phototherapy, blue light is typically used because it is more effective at breaking down bilirubin
(Amato, Inaebnit, 1991). Two matched groups of newborn infants with jaundice were exposed to
intensive green or blue light phototherapy. The efficiency of the treatment was measured by the rate
of decline of serum bilirubin, which in excessive amounts causes jaundice, concentration after 6, 12
and 24 hours of light exposure. A more rapid response was obtained using the blue lamps than the
green lamps. However, a shorter phototherapy recovery period was noticed in babies exposed to the
green lamps(1). Green light is not commonly used because exposure time must be longer to see
dramatic results(1).
Ultraviolet light therapy may increase the risk of skin moles, in childhood. While an increased
number of moles is related to an increased risk of skin cancer,[20][21][22]
it is not ultraviolet light that is
used for treating neonatal jaundice. Rather, it is simply a specific frequency of blue light that does
not carry these risks.
Increased feedings help move bilirubin through the neonates metabolic system.[23]
The light can be applied with overhead lamps, which means that the baby's eyes need to be
covered, or with a device called aBiliblanket,which sits under thebaby's clothingclose to its skin.
http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-17http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-17http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-17http://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-18http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-18http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-18http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-20http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-20http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-22http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-22http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-23http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-23http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-23http://en.wikipedia.org/wiki/Biliblankethttp://en.wikipedia.org/wiki/Biliblankethttp://en.wikipedia.org/wiki/Biliblankethttp://en.wikipedia.org/wiki/Infant_clothinghttp://en.wikipedia.org/wiki/Infant_clothinghttp://en.wikipedia.org/wiki/Infant_clothinghttp://en.wikipedia.org/wiki/Infant_clothinghttp://en.wikipedia.org/wiki/Biliblankethttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-23http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-22http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-20http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-20http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-18http://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-18http://en.wikipedia.org/wiki/Phototherapyhttp://en.wikipedia.org/wiki/Neonatal_jaundice#cite_note-17 -
5/25/2018 Neonatal Jaundice
10/24
Outlook (Prognosis)
Usually newborn jaundice is not harmful. For most babies, jaundice usually gets better without treatment
within 1 to 2 weeks.
Very high levels of bilirubin can damage the brain. This is called kernicterus.However, the condition is
almost always diagnosed before levels become high enough to cause this damage.
For babies who need treatment, the treatment is usually effective.
Possible Complications
Rare, but serious, complications from high bilirubin levels include:
Cerebral palsy
Deafness
Kernicterus -- brain damagefrom very high bilirubin levels
When to Contact a Medical Professional
All babies should be seen by a health care providerin the first 5 days of life to check for jaundice.
Those who spend less than 24 hours in a hospital should be seen by age 72 hours.
Infants sent home between 24 and 48 hours should be seen again by age 96 hours.
Infants sent home between 48 and 72 hours should be seen again by age 120 hours.
Jaundice is an emergency if the baby has a fever, has become listless, or is not feeding well. Jaundice
may be dangerous in high-risk newborns.
Jaundice is generally NOT dangerous in term, otherwise healthy newborns. Call the infant's health care
provider if:
Jaundice is severe (the skin is bright yellow)
Jaundice continues to increase after the newborn visit, lasts longer than 2 weeks, or other
symptoms develop
The feet, especially the soles, are yellow
Prevention
In newborns, some degree of jaundice is normal and probably not preventable. The risk of significant
jaundice can often be reduced by feeding babies at least 8 to 12 times a day for the first several days and
by carefully identifying infants at highest risk.
All pregnant women should be tested for blood type and unusual antibodies. If the mother is Rh negative,
follow-up testing on the infant's cord is recommended. This may also be done if the mother's blood type is
O+, but it is not needed if careful monitoring takes place.
http://www.nlm.nih.gov/medlineplus/ency/article/007309.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/007309.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/007309.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/007309.htm -
5/25/2018 Neonatal Jaundice
11/24
Careful monitoring of all babies during the first 5 days of life can prevent most complications of jaundice.
Ideally, this includes:
Considering a baby's risk for jaundice
Checking bilirubin level in the first day or so
Scheduling at least one follow-up visit the first week of life for babies sent home from the hospital
in 72 hours
Alternative Names
Jaundice of the newborn; Neonatal hyperbilirubinemia; Bili lights - jaundice
-
5/25/2018 Neonatal Jaundice
12/24
is caused by a yellow substance called bilirubin. Infants with high blood levels of bilirubin, called
hyperbilirubinemia, develop the yellow color when bilirubin accumulates in the skin.
Jaundice is not a disease, but is a symptom of an elevated blood bilirubin level. Jaundice is not painful,
but serious complications can occur if elevated bilirubin levels are not treated in a timely manner.
Jaundice is a marker used to identify those infants who may be at risk for developing severe
hyperbilirubinemia. Severe hyperbilirubinemia can be toxic to the nervous system of infants, potentially
causing brain damage.
JAUNDICE SYMPTOMS
Jaundice initially causes the skin to become yellowed. Later, the whites of the eyes may have a yellowish
tinge. These changes may be hard to recognize in children with a dark skin coloror if a baby is unable to
open eyelids. The color change:
Is noticeable in the face first, and may progress down the chest, abdomen, arms, and then finally
thelegs .
Can be checked by pressing one finger on your baby's forehead or nose. If the skin is jaundiced, it
will appear yellow when you release pressure from the skin.
Can be tracked in some babies by pressing over the bony prominences of the chest, hips, and
knees to check if the jaundice is progressing.
Should be checked before your baby leaves the hospital. If your baby goes home sooner than 72
hours after birth, you will need to monitor the baby's skin color at home every day. In addition, your
infant should see a doctor or nurse within one to three days after going home.
Signs of worsening jaundiceCall your child's healthcare providerif you notice any of the following:
If the yellow coloring is at the knee or lower, or if the yellow color is more intense, lemon yellow to
orange yellow
If the baby has any difficulty in feeding
If it is hard to wake up your infant
If your infant is irritable and is difficult to console
If your infant arches his/her neck or body backwards
JAUNDICE CAUSES
Jaundice is caused by the accumulation of bilirubin in the blood. Bilirubin is formed when red blood cells
are broken down. Bilirubin (a yellow pigment) is naturally cleared through the liver, and then excreted in
stool and urine. Bilirubin levels become elevated when bilirubin is produced faster than it can be
eliminated.
Jaundice is common in newborns, since two to three times more bilirubin is produced during this period
as compared with during adulthood. "Physiologic jaundice" or benign jaundice, which affects nearly all
newborns, is caused by a mild elevation of bilirubin and is not usually harmful to infants. It developsbetween 72 and 96 hours after birth, and usually goes away by one to two weeks after birth. In infants
who are born at 35 to 37 weeks of gestation and those who are severely jaundiced, the jaundice may
require more time to resolve.
Newborns with higher levels of bilirubin in the blood have "severe hyperbilirubinemia", a more serious
condition than physiologic jaundice. Infants may develop severe hyperbilirubinemia within the first 24
hours of life. If this happens, you must consult your doctor urgently.
http://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basics -
5/25/2018 Neonatal Jaundice
13/24
One reason that bilirubin levels are higher in infants is that more red blood cells are broken down (and as
a result, more bilirubin is produced). This can be related to:
Bruising and mild injuries from the birth process.
If the mother and infant's blood types are incompatible; the mother's immune system may attack
the infant's red blood cells.
Inherited causes of red blood cell breakdown (such as deficiency of an enzyme called glucose-6-
phosphate dehydrogenase [G6PD], which may occur more frequently among African-American,
Mediterranean, and Asian races).
Asian race or ancestry.
Bilirubin is also more slowly eliminated in the newborn compared with in adults because a newborns liver
and intestines are not fully mature.
BreastfeedingJaundice is common in infants who are breastfed because of two different reasons:
Breastfeeding failure occurs in infants with inadequate intake of breast milkbecause of difficulty in
feeding or if the mother does not have an adequate milk supply. These infants lose a large amount
ofweight ,thereby increasing bilirubin concentration. Increasing the mother's milk supply, frequent
feeding, and ensuring good sucking (latch) are the best treatments for inadequate intake jaundice.
(See"Patient information: Common breastfeeding problems (Beyond the Basics)" .)
Breast milk jaundice is thought to be due to the infants immature liver and intestines. It typically
begins the first week after birth, peaks within two weeks after birth, and declines over the next few
weeks. Breast milk jaundice is not a reason to stop breastfeedingas long as the baby is feeding
well, gaining weight, and otherwise thriving. Infants with breast milk jaundice rarely need treatment
unless severe hyperbilirubinemia develops. All infants with jaundice should be monitored by a doctor
or nurse. (See"Patient information: Common breastfeeding problems (Beyond the Basics)" .)
In either setting, the mother should be encouraged to continue breastfeeding because of the overall
benefits of human milk.
JAUNDICE DIAGNOSIS
Newborn jaundice can be diagnosed by examining the infant and testing blood levels of bilirubin. A blood
test involves collecting a small amount (less than one-half teaspoon or 2.5 mL) of blood. Results of blood
testing are available in most hospitals within a few hours.
JAUNDICE COMPLICATIONS
In babies whose bilirubin blood levels reach harmful levels, bilirubin may get into the brain and cause
reversible damage (called acute bilirubin encephalopathy) or permanent damage (called kernicterus).
Frequent monitoring and early treatment of infants athigh riskfor jaundice can help to prevent severe
hyperbilirubinemia.
JAUNDICE TREATMENT
The goal of jaundice treatment is to quickly and safely reduce the level of bilirubin. Infants with mild
jaundice may need no treatment. Infants with higher bilirubin levels or hyperbilirubinemia will require
treatment, which is described below. (See"Treatment of unconjugated hyperbilirubinemia in term and late
preterm infants".)
http://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants?source=see_linkhttp://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants?source=see_linkhttp://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants?source=see_linkhttp://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants?source=see_linkhttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants?source=see_linkhttp://www.uptodate.com/contents/treatment-of-unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/common-breastfeeding-problems-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basics -
5/25/2018 Neonatal Jaundice
14/24
Jaundice is common in premature infants(those born before 38 weeks of gestation). Premature infants
are at greater risk for hyperbilirubinemia because brain toxicity occurs at lower levels of bilirubin than in
term infants. As a result, premature infants are treated at lower levels of bilirubin, but with the same
treatments discussed here.
Encourage feedingProviding adequate breast milk or formula is an important part of preventing and
treating jaundice because it promotes elimination of the yellow pigment in stools and urine. You will knowthat your child is getting enough milk or formula if s/he has at least six wet diapers per day, the color of
the bowel movements changes from dark green to yellow, and s/he seems satisfied after feeding.
PhototherapyPhototherapy (light therapy) is the most common medical treatment for jaundice in
newborns. In most cases, phototherapy is the only treatment required. It consists of exposing an infant's
skin to a special blue light, which breaks bilirubin down into parts that are easier to eliminate in the stool
and urine. Treatment with phototherapy is successful for almost all infants.
Phototherapy is usually done in the hospital, but in select cases, it can be done in the home if the baby
ishealthy and at low risk for complications.
Infants undergoing phototherapy should have as much skin exposed to the light as possible. Infants areusually naked (or wearing only a diaper) in an open bassinet or warmer, but wear eye patches to protect
the eyes (picture 1). It is important to ensure that the lamps do not generate excessive heat, which could
injure an infant's skin. In some institutions, phototherapy blankets are used (picture 2). Phototherapy
should be continuous, with breaks only for feeding.
Exposure to sunlight was previously thought to be helpful, but is not currently recommended due to the
risk of sunburn. Sunburn does not occur with the lights used in phototherapy when used properly.
Phototherapy is stopped when bilirubin levels decline to a safe level. It is not unusual for infants to still
appear jaundiced after phototherapy is completed. Bilirubin levels may rebound 18 to 24 hours after
stopping phototherapy, although this rarely requires further treatment.
Side effectsPhototherapy is very safe, but it can have temporary side effects, including a skin
rash and loose bowel movements. Overheating and dehydration can occur if the infant does not get
enough breast milk or formula. Therefore, the infant's skin color, body temperature, and number of
wet diapers are closely monitored.
Rarely, some infants will develop "bronze baby" syndrome, a dark, grayish-brown discoloration of
the skin and urine. Bronze baby syndrome is not harmful and gradually resolves without treatment
after several weeks.
HydrationIt is important for infants receiving phototherapy to drink adequate fluids (breast milk or
a supplement) since bilirubin is excreted in urine and bowel movements. Breast- or bottle-feeding
should continue during phototherapy. Use of oral glucose water is not necessary. In some babies
with severe dehydration, intravenous fluids may be necessary.BreastfeedingBreastfed infants who are not able to consume enough breast milk, whose weight
loss is excessive, or who are dehydrated may need extra expressed breast milk or other milk
supplements. Mothers who supplement should continue to breastfeed and/or pump to maintain
their milk supply.
http://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/image?imageKey=PI%2F55964&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/image?imageKey=PI%2F55964&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/image?imageKey=PI%2F55964&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/image?imageKey=PI%2F73723&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/image?imageKey=PI%2F73723&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/image?imageKey=PI%2F73723&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/image?imageKey=PI%2F73723&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/image?imageKey=PI%2F55964&topicKey=PI%2F1203&source=see_linkhttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basics -
5/25/2018 Neonatal Jaundice
15/24
There is some controversy about the practice of using cow milk or soy formula to exclusively breastfed
infants. Parents should discuss these issues with the child's doctor. (See "Patient information:
Breastfeeding guide (Beyond the Basics)".)
Exchange transfusionExchange transfusion is a procedure that is done urgently to prevent or
minimize bilirubin-related brain damage. The transfusion replaces an infant's blood with donated blood in
an attempt to quickly lower bilirubin levels. Exchange transfusion may be performed in infants who have
not responded to other treatments and who have signs of or are at significant neurologic risk of bilirubin
toxicity.
PREVENTION OF SEVERE HYPERBILIRUBINEMIA
Prevention of severe hyperbilirubinemia is important in avoiding serious complications. Infants who are at
risk for hyperbilirubinemia need close surveillance and follow-up. The following information applies to
infants who arehealthy and late preterm or older (greater than or equal to 35 weeks of gestation).
ScreenLeading experts recommend that all infants have bilirubin blood testing before going home.
This is especially true for infants who are jaundiced before 24 hours of age.
MonitorParents and healthcare providers should monitor the infant closely if jaundice develops.
Hyperbilirubinemia is usually easy to prevent and treat initially, but the complications can be serious and
irreversible if treatment is delayed. You should contact your child's healthcare provider immediately if you
are concerned about worsening jaundice.
Treat promptlyInfants with elevated bilirubin levels should be treated by a qualified doctor or nurse to
safely reduce bilirubin levels and prevent the risk of brain damage. Parents and healthcare providers
should not delay treatment for any reason.
http://www.uptodate.com/contents/breastfeeding-guide-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/breastfeeding-guide-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/breastfeeding-guide-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/breastfeeding-guide-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/jaundice-in-newborn-infants-beyond-the-basicshttp://www.uptodate.com/contents/breastfeeding-guide-beyond-the-basics?source=see_linkhttp://www.uptodate.com/contents/breastfeeding-guide-beyond-the-basics?source=see_link -
5/25/2018 Neonatal Jaundice
16/24
Fort Belvoir, Virginia
Am Fam Physician.2002 Feb 15;65(4):599-607.
Patient Information Handout
Hyperbilirubinemia is one of the most common problems encountered in term newborns.Historically, management guidelines were derived from studies on bilirubin toxicity in infants
with hemolytic disease. More recent recommendations support the use of less intensive
therapy inhealthy term newborns with jaundice. Phototherapy should be instituted when
the total serum bilirubin level is at or above 15 mg per dL (257 mol per L) in infants 25 to 48
hours old, 18 mg per dL (308 mol per L) in infants 49 to 72 hours old, and 20 mg per dL (342
mol per L) in infants older than 72 hours. Few term newborns with hyperbilirubinemia have
serious underlying pathology. Jaundice is considered pathologic if it presents within the first
24 hours after birth, the total serum bilirubin level rises by more than 5 mg per dL (86 mol per
L) per day or is higher than 17 mg per dL (290 mol per L), or an infant has signs and
symptoms suggestive of serious illness. The management goals are to exclude pathologiccauses of hyperbilirubinemia and initiate treatment to prevent bilirubin neurotoxicity.
Neonatal hyperbilirubinemia, defined as a total serum bilirubin level above 5 mg per dL (86 molper
L), is a frequently encountered problem. Although up to 60 percent of term newborns have clinical
jaundice in the first week of life, few have significant underlying disease.1,2However,
hyperbilirubinemia in the newborn period can be associated with severe illnesses such as hemolytic
disease, metabolic and endocrine disorders, anatomic abnormalities of the liver, and infections.
Jaundice typically results from the deposition of unconjugated bilirubin pigment in the skin and
mucus membranes. Depending on the underlying etiology, this condition may present throughout the
neonatal period. Unconjugated hyperbilirubinemia, the primary focus of this article, is the most
common form of jaundice encountered by family physicians. The separate topic of conjugated
hyperbilirubinemia is beyond the scope of this article.
Ads by Rich Media ViewAd Options
Risk Factors for Hyperbilirubinemia
Infants without identified risk factors rarely have total serum bilirubin levels above 12 mg per dL (205
mol per L). As the number of risk factors increases, the potential to develop markedly elevated
bilirubin levels also increases.2
Common risk factors for hyperbilirubinemia include fetal-maternal blood group incompatibility,
prematurity, and a previously affected sibling (Table 1).24Cephalohematomas, bruising, and trauma
from instrumented delivery may increase the risk for serum bilirubin elevation. Delayed meconium
passage also increases the risk. Infants with risk factors should be monitored closely during the first
days to weeks of life.
TABLE 1 Risk Factors for Hyperbilirubinemia in Newborns
http://www.aafp.org/afp/2002/0215/p613http://www.aafp.org/afp/2002/0215/p613http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://rvzr-a.akamaihd.net/sd/apps/adinfo-1.0-p/index.html?bj1SaWNoIE1lZGlhIFZpZXcmaD1ydnpyLWEuYWthbWFpaGQubmV0JmM9Z3JlZW4mbz13c2FyJmQ9JnQ9MTsyOzM7NDs1OzY7Nzs4Ozk7MTA7MTE7MTI7MTM7MTQmYT00MzAwJnM9MTAwOSZ3PXd3dy5hYWZwLm9yZyZiPWJkMiZyZD0mcmk9http://rvzr-a.akamaihd.net/sd/apps/adinfo-1.0-p/index.html?bj1SaWNoIE1lZGlhIFZpZXcmaD1ydnpyLWEuYWthbWFpaGQubmV0JmM9Z3JlZW4mbz13c2FyJmQ9JnQ9MTsyOzM7NDs1OzY7Nzs4Ozk7MTA7MTE7MTI7MTM7MTQmYT00MzAwJnM9MTAwOSZ3PXd3dy5hYWZwLm9yZyZiPWJkMiZyZD0mcmk9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b4http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b4http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b4http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b4http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://rvzr-a.akamaihd.net/sd/apps/adinfo-1.0-p/index.html?bj1SaWNoIE1lZGlhIFZpZXcmaD1ydnpyLWEuYWthbWFpaGQubmV0JmM9Z3JlZW4mbz13c2FyJmQ9JnQ9MTsyOzM7NDs1OzY7Nzs4Ozk7MTA7MTE7MTI7MTM7MTQmYT00MzAwJnM9MTAwOSZ3PXd3dy5hYWZwLm9yZyZiPWJkMiZyZD0mcmk9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p613 -
5/25/2018 Neonatal Jaundice
17/24
View Table
Bilirubin Production and Newborns
Bilirubin is the final product of heme degradation. At physiologic pH, bilirubin is insoluble in plasma
and requires protein binding with albumin. After conjugation in the liver, it is excreted in bile.3,57
Newborns produce bilirubin at a rate of approximately 6 to 8 mg per kg per day. This is more than
twice the production rate in adults, primarily because of relative polycythemia and increased red
blood cell turnover in neonates.7Bilirubin production typically declines to the adult level within 10 to
14 days after birth.2
Bilirubin Toxicity
Kernicterus refers to the neurologic consequences of the deposition of unconjugated bilirubin in
brain tissue. Subsequent damage and scarring of the basal ganglia and brainstem nuclei may
occur.5
The precise role of bilirubin in the development of kernicterus is not completely understood. If the
serum unconjugated bilirubin level exceeds the binding capacity of albumin, unbound lipid-soluble
bilirubin crosses the blood-brain barrier. Albumin-bound bilirubin may also cross the blood-brain
barrier if damage has occurred because of asphyxia, acidosis, hypoxia, hypoperfusion,
hyperosmolality, or sepsis in the newborn.3,8
The exact bilirubin concentration associated with kernicterus in thehealthy term infant is
unpredictable.1Toxicity levels may vary among ethnic groups, with maturation of an infant, and in the
presence of hemolytic disease. Although the risk of bilirubin toxicity is probably negligible in a
healthy term newborn without hemolysis,9the physician should become concerned if the bilirubin
level is above 25 mg per dL (428 mol per L).1,3,10In the term newborn with hemolysis, a bilirubinlevel above 20 mg per dL (342 mol per L) is a concern.1,3
The effects of bilirubin toxicity are often devastating and irreversible (Table 2).3,9Early signs of
kernicterus are subtle and nonspecific, typically appearing three to four days after birth. However,
hyperbilirubinemia may lead to kernicterus at any time during the neonatal period.2After the first
week of life, the affected newborn begins to demonstrate late effects of bilirubin toxicity. If the infant
survives the initial severe neurologic insult, chronic bilirubin encephalopathy (evident by three years
of age) leads to developmental and motor delays, sensorineural deafness, and mild mental
retardation.
TABLE 2 Effects of Bilirubin Toxicity in Newborns
View Table
Ads by Rich Media ViewAd Options
Classification of Neonatal Hyperbilirubinemia
http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b8http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b8http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b8http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b8http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b10http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b10http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b10http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://rvzr-a.akamaihd.net/sd/apps/adinfo-1.0-p/index.html?bj1SaWNoIE1lZGlhIFZpZXcmaD1ydnpyLWEuYWthbWFpaGQubmV0JmM9Z3JlZW4mbz13c2FyJmQ9JnQ9MTsyOzM7NDs1OzY7Nzs4Ozk7MTA7MTE7MTI7MTM7MTQmYT00MzAwJnM9MTAwOSZ3PXd3dy5hYWZwLm9yZyZiPWJkMiZyZD0mcmk9http://rvzr-a.akamaihd.net/sd/apps/adinfo-1.0-p/index.html?bj1SaWNoIE1lZGlhIFZpZXcmaD1ydnpyLWEuYWthbWFpaGQubmV0JmM9Z3JlZW4mbz13c2FyJmQ9JnQ9MTsyOzM7NDs1OzY7Nzs4Ozk7MTA7MTE7MTI7MTM7MTQmYT00MzAwJnM9MTAwOSZ3PXd3dy5hYWZwLm9yZyZiPWJkMiZyZD0mcmk9http://www.aafp.org/afp/2002/0215/p599.htmlhttp://rvzr-a.akamaihd.net/sd/apps/adinfo-1.0-p/index.html?bj1SaWNoIE1lZGlhIFZpZXcmaD1ydnpyLWEuYWthbWFpaGQubmV0JmM9Z3JlZW4mbz13c2FyJmQ9JnQ9MTsyOzM7NDs1OzY7Nzs4Ozk7MTA7MTE7MTI7MTM7MTQmYT00MzAwJnM9MTAwOSZ3PXd3dy5hYWZwLm9yZyZiPWJkMiZyZD0mcmk9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b10http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b9http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b8http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3 -
5/25/2018 Neonatal Jaundice
18/24
The causes of neonatal hyperbilirubinemia can be classified into three groups based on mechanism
of accumulation: bilirubin overproduction, decreased bilirubin conjugation, and impaired bilirubin
excretion (Table 3).11
TABLE 3 Classification of Neonatal Hyperbilirubinemia Based on
Mechanism of Accumulation
View Table
PHYSIOLOGIC JAUNDICE
Physiologic jaundice inhealthy term newborns follows a typical pattern. The average total serum
bilirubin level usually peaks at 5 to 6 mg per dL (86 to 103 mol per L) on the third to fourth day of
life and then declines over the first week after birth.2Bilirubin elevations of up to 12 mg per dL, with
less than 2 mg per dL (34 mol per L) of the conjugated form, can sometimes occur. Infants with
multiple risk factors may develop an exaggerated form of physiologic jaundice in which the total
serum bilirubin level may rise as high as 17 mg per dL (291 mol per L) .3
Factors that contribute to the development of physiologic hyperbilirubinemia in the neonate include
an increased bilirubin load because of relative polycythemia, a shortened erythrocyte life span (80
days compared with the adult 120 days), immature hepatic uptake and conjugation processes, and
increased enterohepatic circulation.7
JAUNDICE AND BREASTFEEDINGEarly-Onset Breastfeeding Jaundice
Breast-fed newborns may be at increased risk for early-onset exaggerated physiologic jaundice
because of relative caloric deprivation in the first few days of life.12Decreased volume and frequency
of feedings may result in mild dehydration and the delayed passage of meconium. Compared withformula-fed newborns, breastfed infants are three to six times more likely to experience moderate
jaundice (total serum bilirubin level above 12 mg per dL) or severe jaundice (total serum bilirubin
level above 15 mg per dL [257 mol per L]).12,13
In a breastfed newborn with early-onset hyperbilirubinemia, the frequency of feedings needs to be
increased to more than 10 per day. If the infant has a decline in weight gain, delayed stooling, and
continued poor caloric intake, formula supplementation may be necessary, but breastfeeding should
be continued to maintain breast milk production. Supplemental water or dextrose-water
administration should be avoided, as it decreases breast milk production and places the newborn at
risk for iatrogenic hyponatremia.3,5,11
Late-Onset Breast Milk Jaundice
Breast milk jaundice occurs later in the newborn period, with the bilirubin level usually peaking in the
sixth to 14th days of life. This late-onset jaundice may develop in up to one third ofhealthy
breastfed infants.1Total serum bilirubin levels vary from 12 to 20 mg per dL (340 mol per L) and
are nonpathologic.
http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b13http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b13http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b13http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b13http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b13http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b12http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b11http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-t3 -
5/25/2018 Neonatal Jaundice
19/24
The underlying cause of breast milk jaundice is not entirely understood. Substances in maternal
milk, such as -glucuronidases, and nonesterified fatty acids, may inhibit normal bilirubinmetabolism
.5,7,14,15The bilirubin level usually falls continually after the infant is two weeks old, but it may remain
persistently elevated for one to three months.
If the diagnosis of breast milk jaundice is in doubt or the total serum bilirubin level becomesmarkedly elevated, breastfeeding may be temporarily interrupted, although the mother should
continue to express breast milk to maintain production. With formula substitution, the total serum
bilirubin level should decline rapidly over 48 hours (at a rate of 3 mg per dL [51 mol per L] per
day),1confirming the diagnosis. Breastfeeding may then be resumed.
PATHOLOGIC JAUNDICE
All etiologies of jaundice beyond physiologic and breastfeeding or breast milk jaundice are
considered pathologic. Features of pathologic jaundice include the appearance of jaundice within 24
hours after birth, a rapidly rising total serum bilirubin concentration (increase of more than 5 mg per
dL per day), and a total serum bilirubin level higher than 17 mg per dL in a full-term newborn.3,5
Otherfeatures of concern include prolonged jaundice, evidence of underlying illness, and elevation of the
serum conjugated bilirubin level to greater than 2 mg per dL or more than 20 percent of the total
serum bilirubin concentration. Pathologic causes include disorders such as sepsis, rubella,
toxoplasmosis, occult hemorrhage, and erythroblastosis fetalis.
Diagnosis
PHYSICAL EXAMINATION
The presence of jaundice can be determined by examining the infant in a well-lit room and blanching
the skin with digital pressure to reveal the color of the skin and subcutaneous tissue. Neonatal
dermal icterus is not noticeable at total serum bilirubin levels below 4 mg per dL (68 mol per L).16
Increasing total serum bilirubin levels are accompanied by the cephalocaudal progression of dermal
icterus, predictably from the face to the trunk and extremities, and finally to the palms and
soles.16,17The total serum bilirubin level can be estimated clinically by the degree of caudal extension:
face, 5 mg per dL; upper chest, 10 mg per dL (171 mol per L); abdomen, 12 mg per dL; palms and
soles, greater than 15 mg per dL.
The only consistently reliable estimation of total serum bilirubin occurs when dermal icterus is
confined to above the nipple line. In this situation, the bilirubin level is invariably below 12 mg per dL.
As jaundice extends below the middle of the chest, the correlation between physical signs and
measured bilirubin levels becomes increasingly unreliable. Differences in skin color among races,
delays in dermal deposition with rapidly rising bilirubin levels, interobserver variability, and other
factors contribute to the difficulty of accurately predicting the total serum bilirubin concentration
based on caudal progression alone.18
http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b14http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b14http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b14http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b15http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b15http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b15http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b17http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b17http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b17http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b18http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b18http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b18http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b18http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b17http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b16http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b3http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b15http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b14http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b7http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b5http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html -
5/25/2018 Neonatal Jaundice
20/24
The physical examination should focus on identifying one of the known causes of pathologic
jaundice. The infant should be assessed for pallor, petechiae, extravasated blood, excessive
bruising, hepatosplenomegaly,weight loss, and evidence of dehydration.
LABORATORY EVALUATION
The initial evaluation of jaundice depends on the age of the newborn (Figure 1).2If the serum
conjugated bilirubin level is above 2 mg per dL, the infant should be evaluated for possible
hepatocellular disease or biliary obstruction.
Laboratory Evaluation of Term Newborn with Jaundice
FIGURE 1.
Algorithm for the suggested evaluation of a term newborn with hyperbilirubinemia.
http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-f1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-f1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-f1http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.html#afp20020215p599-b2http://www.aafp.org/afp/2002/0215/p599.htmlhttp://www.aafp.